Join
Live feed
·
INSIDERFilingvia Quantisnow
Terns Pharmaceuticals Inc. logo

Chief Executive Officer Burroughs Amy L. sold $2,548,603 worth of shares (68,749 units at $37.07), was granted 150,000 shares and exercised 68,749 shares at a strike of $4.64, increasing direct ownership by 108% to 288,976 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TERN (Terns Pharmaceuticals Inc.) and more on Quantisnow.